The effect of time to castration resistance on overall survival and success of docetaxel treatment in castration resistant prostate cancer patients.
CONCLUSION: TTCR appears to be an independent prognostic factor for patients who are candidates for DCR.
PMID: 30636274 [PubMed - as supplied by publisher]
Source: Urology Journal - Category: Urology & Nephrology Authors: Suer E, Hamidi N, Akpinar C, Gokce MI, Gulpinar O, Turkolmez K, Beduk Y, Baltaci S Tags: Urol J Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Docetaxel | Hormones | Prostate Cancer | Statistics | Taxotere | Urology & Nephrology